**Core Concept**
β thalassemia major is a severe form of thalassemia, a genetic disorder affecting hemoglobin production. It results from mutations in the HBB gene, leading to reduced or absent production of the beta-globin chains of hemoglobin. This causes severe anemia, bone deformities, and other complications.

**Why the Correct Answer is Right**
The correct answer is related to the clinical features of β thalassemia major. Patients with this condition typically present with severe anemia, which requires regular blood transfusions. They also develop bone deformities due to marrow expansion, and have a increased risk of infections and other complications. The spleen may become enlarged (splenomegaly) due to the increased breakdown of red blood cells.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not a feature of β thalassemia major. Patients with this condition typically have a significant reduction in hemoglobin production, not an increase.
**Option B:** This option is incorrect because β thalassemia major is associated with anemia, not polycythemia (an increase in red blood cell count).
**Option C:** This option is not a feature of β thalassemia major. While patients with this condition may have some degree of jaundice, it is not a characteristic feature of the disease.

**Clinical Pearl / High-Yield Fact**
The diagnosis of β thalassemia major is typically made through a combination of clinical features, blood tests, and genetic analysis. It is essential to differentiate it from other causes of anemia, such as iron deficiency anemia.

**Correct Answer: D. This option is not a feature of β thalassemia major.**